Free Trial
TSE:NVCN

Neovasc (NVCN) Stock Price, News & Analysis

Neovasc logo

About Neovasc Stock (TSE:NVCN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
399 shs
Average Volume
2,123 shs
Market Capitalization
C$110.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Stock News Headlines

Aptose Biosciences Inc (APS)
Closing Bell: Neovasc Inc up on Thursday (NVCN)
What President Trump’s Executive Order 14154 means for your money
Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.
Shockwave Medical to Acquire Neovasc
Shockwave Medical to Buy Neovasc for $75 Million
Neovasc Inc. (NVCN) Q3 2022 Earnings Call Transcript
See More Headlines

NVCN Stock Analysis - Frequently Asked Questions

Shares of NVCN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Bionano Genomics (BNGO) and Meta Platforms (META).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Surgical & Medical Instrument Manufacturing
Sub-Industry
Medical Equipment
Current Symbol
TSE:NVCN
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-33,520,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$3.11 million
Price / Cash Flow
1.05
Book Value
C$10.22 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$110.81 million
Optionable
Not Optionable
Beta
2.01
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (TSE:NVCN) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners